Another player involved in CD44v9-xCT complex stabilization is mucin 1 (MUC1) – a transmembrane glycoprotein commonly overexpressed in a plethora of cancers including lung, colon, breast, pancreatic and ovarian cancers (Chen et al., 2021; Figure 4A). Here, MUC1 is linked to ovarian carcinoma.